Axonics Investor Relations Material

Axonics Inc is a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder dysfunction. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention.